Zimmer Biomet Holdings (ZBH) Gets a Hold from Truist Financial
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
Business Insider1mon
Zimmer Biomet price target lowered to $107 from $115 at Deutsche Bank
Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Zimmer Biomet (ZBH) to $107 from $115 and keeps a Hold rating on the shares following the “choppy” Q4 print.
Zimmer Biomet Q1 EPS Forecast Reduced by Zacks Research
Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...